Matches in SemOpenAlex for { <https://semopenalex.org/work/W3163670610> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W3163670610 endingPage "2436" @default.
- W3163670610 startingPage "2431" @default.
- W3163670610 abstract "Platelet-rich plasma (PRP) is an autologous blood product which has recently been used in multiple spheres of dermatology including facial rejuvenation, androgenetic alopecia, acne scars, and wound healing. Its use in melasma is comparatively an understudied topic.An extensive systematic literature search of the PubMed electronic database and Cochrane central register of controlled trials was done using the keywords platelet rich plasma and melasma in the title. Relevant studies were selected and data were analyzed by two different authors. Four articles were excluded as they did not adhere to the inclusion criteria of this review and a total of 6 articles were reviewed.The relevant references of the included articles were also traced and included.These studies showed that PRP has been used effectively not only as an adjuvant therapy but also as a standalone treatment for melasma. PRP contains about 30 growth factors, transforming growth factor beta (TGF-β) being one of the growth factors having a predominant role in treatment of melasma. TGF-β decreases signal transduction of microphthalmia-induced transcription factor and thus decreases tyrosinase and tyrosinase-related proteins. In addition to this, PRP also has an additional benefit of inducing collagen synthesis thus improving the quality and texture of the skin. But there is a scarcity of data and large randomized controlled trials. This review is an effort to highlight and upscale the use of this excellent blood product for melasma which is quite a treatment refractory disorder." @default.
- W3163670610 created "2021-05-24" @default.
- W3163670610 creator A5012061198 @default.
- W3163670610 creator A5021458576 @default.
- W3163670610 creator A5060966877 @default.
- W3163670610 date "2021-06-03" @default.
- W3163670610 modified "2023-10-18" @default.
- W3163670610 title "Platelet‐rich plasma is a promising therapy for melasma" @default.
- W3163670610 cites W1884674090 @default.
- W3163670610 cites W1983106010 @default.
- W3163670610 cites W1987537856 @default.
- W3163670610 cites W1990368513 @default.
- W3163670610 cites W1996837920 @default.
- W3163670610 cites W2007491669 @default.
- W3163670610 cites W2007764579 @default.
- W3163670610 cites W2023413668 @default.
- W3163670610 cites W2039356308 @default.
- W3163670610 cites W2064413596 @default.
- W3163670610 cites W2067737640 @default.
- W3163670610 cites W2070440859 @default.
- W3163670610 cites W2080116170 @default.
- W3163670610 cites W2107363885 @default.
- W3163670610 cites W2111034403 @default.
- W3163670610 cites W2114845873 @default.
- W3163670610 cites W2115071308 @default.
- W3163670610 cites W2121511326 @default.
- W3163670610 cites W2588366390 @default.
- W3163670610 cites W2892092373 @default.
- W3163670610 cites W2924501347 @default.
- W3163670610 cites W2949736964 @default.
- W3163670610 cites W2977387290 @default.
- W3163670610 cites W3036740537 @default.
- W3163670610 cites W3132061501 @default.
- W3163670610 cites W82536280 @default.
- W3163670610 doi "https://doi.org/10.1111/jocd.14229" @default.
- W3163670610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34013618" @default.
- W3163670610 hasPublicationYear "2021" @default.
- W3163670610 type Work @default.
- W3163670610 sameAs 3163670610 @default.
- W3163670610 citedByCount "11" @default.
- W3163670610 countsByYear W31636706102022 @default.
- W3163670610 countsByYear W31636706102023 @default.
- W3163670610 crossrefType "journal-article" @default.
- W3163670610 hasAuthorship W3163670610A5012061198 @default.
- W3163670610 hasAuthorship W3163670610A5021458576 @default.
- W3163670610 hasAuthorship W3163670610A5060966877 @default.
- W3163670610 hasConcept C126322002 @default.
- W3163670610 hasConcept C16005928 @default.
- W3163670610 hasConcept C2776677263 @default.
- W3163670610 hasConcept C2777863537 @default.
- W3163670610 hasConcept C2780076745 @default.
- W3163670610 hasConcept C71924100 @default.
- W3163670610 hasConcept C89560881 @default.
- W3163670610 hasConceptScore W3163670610C126322002 @default.
- W3163670610 hasConceptScore W3163670610C16005928 @default.
- W3163670610 hasConceptScore W3163670610C2776677263 @default.
- W3163670610 hasConceptScore W3163670610C2777863537 @default.
- W3163670610 hasConceptScore W3163670610C2780076745 @default.
- W3163670610 hasConceptScore W3163670610C71924100 @default.
- W3163670610 hasConceptScore W3163670610C89560881 @default.
- W3163670610 hasIssue "8" @default.
- W3163670610 hasLocation W31636706101 @default.
- W3163670610 hasLocation W31636706102 @default.
- W3163670610 hasOpenAccess W3163670610 @default.
- W3163670610 hasPrimaryLocation W31636706101 @default.
- W3163670610 hasRelatedWork W3000588231 @default.
- W3163670610 hasRelatedWork W3099368603 @default.
- W3163670610 hasRelatedWork W3167447492 @default.
- W3163670610 hasRelatedWork W3168221830 @default.
- W3163670610 hasRelatedWork W3216758556 @default.
- W3163670610 hasRelatedWork W4200111320 @default.
- W3163670610 hasRelatedWork W4284690728 @default.
- W3163670610 hasRelatedWork W4285794454 @default.
- W3163670610 hasRelatedWork W4318829708 @default.
- W3163670610 hasRelatedWork W4375844220 @default.
- W3163670610 hasVolume "20" @default.
- W3163670610 isParatext "false" @default.
- W3163670610 isRetracted "false" @default.
- W3163670610 magId "3163670610" @default.
- W3163670610 workType "article" @default.